Carlisle Companies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.10.20	Carlisle Companies Q3 Profit Down (RTTNews)
21.07.20	Carlisle Companies Q2 Profit Falls; Organic Revenue Down 23.8% (RTTNews)
21.04.20	Carlisle Companies Q1 Profit Down (RTTNews)
06.02.20	Carlisle Companies Q4 Profit Up (RTTNews)
22.10.19	Carlisle Companies Submits Offer To Acquire Draka Fileca From Prysmian (RTTNews)
23.07.19	Carlisle Companies Inc. Earnings Rise In Q2 (RTTNews)
24.04.19	Interesting Stocks To Watch On April 24 (RTTNews)
23.04.19	Carlisle Q1 Profit Tops Estimates; Shares Rise 5% - Quick Facts (RTTNews)
24.07.18	Carlisle Companies Inc. Q2 Income Advances (RTTNews)
31.05.18	IDELVION® Newly Approved 3500 IU Vial to Provide Convenience to Patients Using Larger Volumes (PR Newswire)
14.05.18	Hemophilia Association Of New Jersey Recognizes CSL CEO Paul Perreault As "Humanitarian Man Of The Year" (PR Newswire)
06.05.18	Carlisle Companies Announces Director Change (RTTNews)
26.04.18	Patient Advocacy Groups Focus On Key Issues Affecting Patients (PR Newswire)
25.04.18	New College Ranking and Review Aggregator Publishes Top Consensus Ranked Regional Universities in Midwest for 2018 (PR Newswire)
24.04.18	Carlisle Companies Issues FY18 Revenue Guidance - Quick Facts (RTTNews)
24.04.18	Carlisle Companies Inc. Q1 Earnings Rise (RTTNews)
20.04.18	CSL Behring, Leader in Rare Diseases, Showcases Innovations in Neuromuscular Medicine (NMM) at the 2018 American Academy of Neurology Annual Meeting (PR Newswire)
19.04.18	The Lancet publishes results demonstrating adjuvanted quadrivalent influenza vaccine provides significantly greater efficacy in children 6 through 23 months (PR Newswire)
12.04.18	Life-Saving Medicines Donated For Patients In The Developing World (PR Newswire)
23.03.18	CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors (PR Newswire)
23.03.18	CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors (PR Newswire)
20.03.18	Forbes Magazine Names CSL Limited Among Top 50 Employers in the World (PR Newswire)
16.03.18	FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (PR Newswire)
15.03.18	CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks (PR Newswire)
13.03.18	CSL CEO Paul Perreault Calls on Industry to Improve Patients' Access to Medicines (PR Newswire)
13.03.18	CSL CEO Paul Perreault Calls on Industry to Improve Patients' Access to Medicines (PR Newswire)
13.03.18	Seqirus answers the call for better and faster influenza vaccine technologies (PR Newswire)
08.02.18	Carlisle Companies Inc. Bottom Line Advances In Q4 (RTTNews)
01.02.18	Carlisle Companies To Sell Carlisle FoodService Products For $750 Mln In Cash (RTTNews)
07.12.17	Rogers Communications announces changes to Board of Directors (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
04.12.17	CSL Behring Advances to Phase 3 Cardiovascular Outcomes Trial for CSL112, its Novel Apolipoprotein A-I (Human) Infusion Therapy (PR Newswire)
16.11.17	SQI Diagnostics Reports Fourth Quarter and Fiscal 2017 Results (PR Newswire)
09.11.17	Lancet Neurology Publishes Results from CSL Behring Phase III Study of Hizentra® (Immune Globulin Subcutaneous [Human] 20% liquid) as Maintenance Therapy in Patients with Chronic Inflammatory... (PR Newswire)
29.10.17	Data on the Preventive Effects of HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) in Subjects with Very Frequent HAE Attacks Presented by CSL Behring at the 2017 ACAAI Annual Scientific Meeting (PR Newswire)
24.10.17	Carlisle Companies Inc. Q3 Earnings Decline 24% (RTTNews)
24.10.17	New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting (PR Newswire)
12.10.17	CSL Behring Trains Employees to Save Lives in Their Communities and Workplace with CPR; AHA Encourages Other Businesses to Do the Same (PR Newswire)
02.10.17	Carlisle To Acquire Accella For $670 Mln - Quick Facts (RTTNews)
02.10.17	Arsenal Announces Sale of Accella Performance Materials to Carlisle Companies (PR Newswire)
28.09.17	Japan's Ministry of Health, Labour and Welfare Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment (PR Newswire)
26.09.17	Avis aux médias - Le ministre célèbre le 150e anniversaire du Canada à la Ferme expérimentale centrale (PR Newswire)
26.09.17	AVIS - Le CN divulguera ses résultats financiers et d'exploitation du troisième trimestre de 2017 le 24 octobre 2017 (PR Newswire)
22.09.17	Avis aux médias : Annonce en matière d'infrastructure en Alberta (PR Newswire)
22.09.17	Moody's upgrades perspective to stable and confirms Ecopetrol S.A.'s investment-grade rating (PR Newswire)
19.09.17	CSL Behring Will Help Transform Biotech Education and Research with $4.92 Million Gift to Penn State (PR Newswire)
15.09.17	CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults (PR Newswire)
14.09.17	CSL Behring Joins Together With Conference Attendees to Make Donation to IPOPI (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Carlisle Companies Inc.

Aktien Top/Flop

Meistgelesene Nachrichten